These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6307259)

  • 1. Inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid.
    Arisawa M; Then R
    Biochem J; 1983 Mar; 209(3):609-15. PubMed ID: 6307259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid.
    Arisawa M; Adam S
    Biochem J; 1983 May; 211(2):447-54. PubMed ID: 6307281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5833-9. PubMed ID: 6098299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).
    Labia R; Lelievre V; Peduzzi J
    Biochim Biophys Acta; 1980 Feb; 611(2):351-7. PubMed ID: 6243991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.
    Pratt RF; Loosemore MJ
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4145-9. PubMed ID: 212736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of beta-lactamase inhibition by clavulanic acid].
    Labia R; Peduzzi J
    Biochim Biophys Acta; 1978 Oct; 526(2):572-9. PubMed ID: 363163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated beta-lactamases.
    Arisawa M; Then RL
    J Antibiot (Tokyo); 1982 Nov; 35(11):1578-83. PubMed ID: 6298167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
    Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.
    Christensen H; Martin MT; Waley SG
    Biochem J; 1990 Mar; 266(3):853-61. PubMed ID: 2158301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.
    Bush K; Macalintal C; Rasmussen BA; Lee VJ; Yang Y
    Antimicrob Agents Chemother; 1993 Apr; 37(4):851-8. PubMed ID: 8388201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENDOR structural characterization of a catalytically competent acylenzyme reaction intermediate of wild-type TEM-1 beta-lactamase confirms glutamate-166 as the base catalyst.
    Mustafi D; Sosa-Peinado A; Makinen MW
    Biochemistry; 2001 Feb; 40(8):2397-409. PubMed ID: 11327860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
    Kemal C; Knowles JR
    Biochemistry; 1981 Jun; 20(13):3688-95. PubMed ID: 6268141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
    Reading C; Farmer T
    Biochem J; 1981 Dec; 199(3):779-87. PubMed ID: 7041890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.
    Knap AK; Pratt RF
    Biochem J; 1987 Oct; 247(1):29-33. PubMed ID: 2825657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of inactivation of beta-lactamase I by 6 beta-bromopenicillanic acid.
    Knott-Hunziker V; Orlek BS; Sammes PG; Waley SG
    Biochem J; 1980 Jun; 187(3):797-802. PubMed ID: 6331385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
    Ness S; Martin R; Kindler AM; Paetzel M; Gold M; Jensen SE; Jones JB; Strynadka NC
    Biochemistry; 2000 May; 39(18):5312-21. PubMed ID: 10820001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.